Calls for Increased Funding in Australia's Home Medicine Review Program
Patients in need of home pharmacy help missing out due to caps
AbcImage: Abc
Pharmacists across Australia are advocating for changes to the Home Medicine Review program, which currently limits funding to 30 patients per month for at-home medication reviews. This cap restricts access to vital services for many patients, particularly in rural areas, where chronic diseases are prevalent.
- 01The Home Medicine Review program has a cap of 30 patients per month, limiting access to necessary medication reviews.
- 02Pharmacists argue that the funding cap forces them to choose which patients receive care, creating inequities.
- 03The funding for at-home medication reviews has not been updated since 2019, despite rising costs.
- 04Telehealth options for medication reviews were effective during the COVID-19 pandemic but are currently not available.
- 05The Pharmaceutical Society of Australia is urging the government to reinstate telehealth funding to improve access.
Advertisement
In-Article Ad
Pharmacists in Australia are calling for reforms to the Home Medicine Review program, which currently restricts funding to 30 patients per month for at-home medication reviews. This limitation has created challenges for patients, especially in rural areas like the Mallee region of Victoria, where chronic diseases are prevalent. Pharmacist Brooke Shelley highlighted the unfairness of the cap, stating that it forces professionals to choose who receives care, while patients with urgent medication needs are left waiting. The funding for these reviews has not been updated since 2019, leading to difficulties in sustaining the service amidst rising costs. The Pharmaceutical Society of Australia (PSA) has urged the federal government to reinstate telehealth funding, which was effective during the COVID-19 pandemic, to enhance access for patients. A government spokesperson noted that the cap was increased from 20 to 30 patients in 2020 to maintain program sustainability, but further changes remain uncertain.
Advertisement
In-Article Ad
The current funding cap limits access to essential medication management services, particularly affecting patients in rural areas who may rely heavily on pharmacists for support.
Advertisement
In-Article Ad
Reader Poll
Do you support increasing the funding cap for home medicine reviews?
Connecting to poll...
Read the original article
Visit the source for the complete story.


